click below
click below
Normal Size Small Size show me how
Pharmacology
| Term | Definition |
|---|---|
| Pharmacology | |
| Drug | |
| Medicine | |
| Poison | |
| Pharmacodynamics | |
| Pharmacokinetics | |
| Chemical name | |
| Generic name | |
| Proprietary, trade or brand name | |
| Pharmacogenetics | |
| Pharmacoepidemilogy | |
| Pharmacoeconomics | |
| Pharmacogenomics | |
| Nonspecific | |
| Specific | |
| Carrier Molecule | |
| Facilitated diffusion | |
| Active Transport | |
| Enzyme | |
| Receptor | |
| Competitive inhibitor | |
| Reversible inhibitor | |
| Non competitive inhibitor | |
| Ion channel | |
| Ion channel - direct target | |
| Ion channel - receptor linked channel | |
| Ligand | |
| Selectivity | |
| Sensitivity | |
| Specificity | |
| Agonist | |
| Antagonist | |
| Reversible agonist | |
| Irreversible agonist | |
| Ligand- gated channel | |
| G-protein coupled | |
| Kinase-linked | |
| Intracellular steroid receptor | |
| G-protein | |
| Affinity | |
| Partial agonist | |
| Full agonist | |
| Competitive agonist | |
| Potency | |
| Dose ratio | |
| Crete for competitive antagonism | |
| pA2 | |
| EC50 | |
| Efficacy | |
| Competitive antagonist | |
| Irreversible antagonist | |
| inverse agonist | |
| biased agonism | |
| allosteric modulation |